{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T08:29:43Z","timestamp":1793780983460,"version":"4.6.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T00:00:00Z","timestamp":1644796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T00:00:00Z","timestamp":1644796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod. Sci."],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s43032-022-00881-7","type":"journal-article","created":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T16:31:13Z","timestamp":1644856273000},"page":"1209-1214","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Ruptured ectopic pregnancies following methotrexate treatment: clinical course and predictors for improving patient counseling"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3856-6056","authenticated-orcid":false,"given":"Aviad","family":"Cohen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shikma","family":"Bar-on","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoni","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ori","family":"Sandel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuval","family":"Fouks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadav","family":"Michaan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamar","family":"Tzur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishai","family":"Levin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,14]]},"reference":[{"issue":"6","key":"881_CR1","first-page":"1326","volume":"102","author":"SJ Whitehead","year":"2003","unstructured":"Whitehead SJ, Berg CJ, Chang J. Pregnancy-related mortality due to cardiomyopathy: United States, 1991-1997. Obstet Gynecol. 2003;102(6):1326\u201331.","journal-title":"Obstet Gynecol"},{"issue":"9080","key":"881_CR2","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/S0140-6736(97)05487-1","volume":"350","author":"PJ Hajenius","year":"1997","unstructured":"Hajenius PJ, et al. Randomised trial of systemic methotrexate versus laparoscopic salpingostomy in tubal pregnancy. Lancet. 1997;350(9080):774\u20139.","journal-title":"Lancet"},{"key":"881_CR3","first-page":"CD000324","volume":"1","author":"PJ Hajenius","year":"2007","unstructured":"Hajenius PJ, et al. Interventions for tubal ectopic pregnancy. Cochrane Database Syst Rev. 2007;1:CD000324.","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"881_CR4","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1111\/j.1471-0528.1998.tb10271.x","volume":"105","author":"RP Woolas","year":"1998","unstructured":"Woolas RP, et al. Influence of chemotherapy for gestational trophoblastic disease on subsequent pregnancy outcome. Br J Obstet Gynaecol. 1998;105(9):1032\u20135.","journal-title":"Br J Obstet Gynaecol"},{"issue":"5","key":"881_CR5","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1016\/j.fertnstert.2004.03.066","volume":"82","author":"PS Dudley","year":"2004","unstructured":"Dudley PS, et al. Characterizing ectopic pregnancies that rupture despite treatment with methotrexate. Fertil Steril. 2004;82(5):1374\u20138.","journal-title":"Fertil Steril"},{"issue":"26","key":"881_CR6","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1056\/NEJM199912233412604","volume":"341","author":"GH Lipscomb","year":"1999","unstructured":"Lipscomb GH, et al. Predictors of success of methotrexate treatment in women with tubal ectopic pregnancies. N Engl J Med. 1999;341(26):1974\u20138.","journal-title":"N Engl J Med"},{"issue":"2","key":"881_CR7","doi-asserted-by":"publisher","first-page":"128 e1-5","DOI":"10.1016\/j.ajog.2014.03.043","volume":"211","author":"A Cohen","year":"2014","unstructured":"Cohen A, et al. Methotrexate success rates in progressing ectopic pregnancies: a reappraisal. Am J Obstet Gynecol. 2014;211(2):128 e1-5.","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"881_CR8","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.fertnstert.2013.06.013","volume":"100","author":"Practice Committee of American Society for reproductive","year":"2013","unstructured":"Practice Committee of American Society for reproductive. Medical treatment of ectopic pregnancy: a committee opinion. Fertil Steril. 2013;100(3):638\u201344.","journal-title":"Fertil Steril"},{"key":"881_CR9","doi-asserted-by":"crossref","unstructured":"Barnhart, K., M. Esposito, and C. Coutifaris, An update on the medical treatment of ectopic pregnancy. Obstet Gynecol Clin N Am, 2000. 27(3): p. 653\u2013667, viii.","DOI":"10.1016\/S0889-8545(05)70162-5"},{"issue":"4","key":"881_CR10","first-page":"778","volume":"101","author":"KT Barnhart","year":"2003","unstructured":"Barnhart KT, et al. The medical management of ectopic pregnancy: a meta-analysis comparing \"single dose\" and \"multidose\" regimens. Obstet Gynecol. 2003;101(4):778\u201384.","journal-title":"Obstet Gynecol"},{"key":"881_CR11","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ejogrb.2016.11.016","volume":"208","author":"L Bonin","year":"2017","unstructured":"Bonin L, et al. Predictive factors for the methotrexate treatment outcome in ectopic pregnancy: a comparative study of 400 cases. Eur J Obstet Gynecol Reprod Biol. 2017;208:23\u201330.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"881_CR12","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.ejogrb.2018.04.020","volume":"225","author":"JH Lee","year":"2018","unstructured":"Lee JH, et al. A risk prediction model for medical treatment failure in tubal pregnancy. Eur J Obstet Gynecol Reprod Biol. 2018;225:148\u201354.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"881_CR13","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1080\/09513590.2018.1490406","volume":"35","author":"AP Hutchinson","year":"2019","unstructured":"Hutchinson AP, et al. Risk factors and human chorionic gonadotropin trends in patients with ruptured tubal ectopic pregnancies despite methotrexate treatment. Gynecol Endocrinol. 2019;35(1):49\u201352.","journal-title":"Gynecol Endocrinol"},{"issue":"4","key":"881_CR14","first-page":"590","volume":"93","author":"GH Lipscomb","year":"1999","unstructured":"Lipscomb GH, et al. Management of separation pain after single-dose methotrexate therapy for ectopic pregnancy. Obstet Gynecol. 1999;93(4):590\u20133.","journal-title":"Obstet Gynecol"},{"issue":"6","key":"881_CR15","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/S0736-4679(98)00098-5","volume":"16","author":"K Heard","year":"1998","unstructured":"Heard K, Kendall J, Abbott J. Rupture of ectopic pregnancy after medical therapy with methotrexate: a case series. J Emerg Med. 1998;16(6):857\u201360.","journal-title":"J Emerg Med"},{"issue":"7","key":"881_CR16","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1080\/01443615.2017.1312308","volume":"37","author":"H Qayyum","year":"2017","unstructured":"Qayyum H, et al. Ruptured ectopic pregnancy with a negative urinary pregnancy test after methotrexate treatment - challenges of diagnosis in the emergency department. J Obstet Gynaecol. 2017;37(7):958\u20139.","journal-title":"J Obstet Gynaecol"},{"key":"881_CR17","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ejogrb.2017.02.007","volume":"211","author":"A Cohen","year":"2017","unstructured":"Cohen A, et al. The role of HCG increment in the 48h prior to methotrexate treatment as a predictor for treatment success. Eur J Obstet Gynecol Reprod Biol. 2017;211:103\u20137.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"9","key":"881_CR18","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1093\/humrep\/del170","volume":"21","author":"FR Cabar","year":"2006","unstructured":"Cabar FR, et al. Predictive factors of trophoblastic invasion into the ampullary region of the tubal wall in ectopic pregnancy. Hum Reprod. 2006;21(9):2426\u201331.","journal-title":"Hum Reprod"},{"issue":"2","key":"881_CR19","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1093\/humrep\/12.2.383","volume":"12","author":"H Kiss","year":"1997","unstructured":"Kiss H, et al. Proliferative cell activity in correlation to human chorionic gonadotrophin release of trophoblast tissue of tubal pregnancy. Hum Reprod. 1997;12(2):383\u20136.","journal-title":"Hum Reprod"}],"container-title":["Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-022-00881-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43032-022-00881-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-022-00881-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T16:47:28Z","timestamp":1646844448000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43032-022-00881-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,14]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["881"],"URL":"https:\/\/doi.org\/10.1007\/s43032-022-00881-7","relation":{},"ISSN":["1933-7191","1933-7205"],"issn-type":[{"value":"1933-7191","type":"print"},{"value":"1933-7205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,14]]},"assertion":[{"value":"12 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Tel-Aviv medical center IRB approval number: 0208\u201318-TLV.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}